GB201715421D0 - Assays and medical uses - Google Patents

Assays and medical uses

Info

Publication number
GB201715421D0
GB201715421D0 GBGB1715421.2A GB201715421A GB201715421D0 GB 201715421 D0 GB201715421 D0 GB 201715421D0 GB 201715421 A GB201715421 A GB 201715421A GB 201715421 D0 GB201715421 D0 GB 201715421D0
Authority
GB
United Kingdom
Prior art keywords
assays
medical uses
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1715421.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1715421.2A priority Critical patent/GB201715421D0/en
Publication of GB201715421D0 publication Critical patent/GB201715421D0/en
Priority to PCT/GB2018/052701 priority patent/WO2019058136A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1715421.2A 2017-09-22 2017-09-22 Assays and medical uses Ceased GB201715421D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1715421.2A GB201715421D0 (en) 2017-09-22 2017-09-22 Assays and medical uses
PCT/GB2018/052701 WO2019058136A1 (en) 2017-09-22 2018-09-21 Assays and medical uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1715421.2A GB201715421D0 (en) 2017-09-22 2017-09-22 Assays and medical uses

Publications (1)

Publication Number Publication Date
GB201715421D0 true GB201715421D0 (en) 2017-11-08

Family

ID=60244470

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1715421.2A Ceased GB201715421D0 (en) 2017-09-22 2017-09-22 Assays and medical uses

Country Status (2)

Country Link
GB (1) GB201715421D0 (en)
WO (1) WO2019058136A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090253769A1 (en) * 2004-01-21 2009-10-08 Gessica Filocamo Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders

Also Published As

Publication number Publication date
WO2019058136A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
IL290842A (en) Anti-cd73 antibodies and uses thereof
IL273236A (en) Pyrazolopyrimidinone compounds and uses thereof
ZA202102905B (en) Anti-galectin-9 antibodies and uses thereof
ZA202101318B (en) Anti-phf-tau antibodies and uses thereof
IL268734A (en) Anti-lag-3 antibodies and uses thereof
IL271477A (en) Anti-cd166 antibodies and uses thereof
IL293377B1 (en) Hsd17b13 variants and uses thereof
IL269134A (en) Anti-par2 antibodies and uses thereof
GB201714745D0 (en) New compounds and uses
IL264813B (en) 2-oxo-imidazopyridines and their use
GB201714740D0 (en) New compounds and uses
IL272476A (en) Anti-apelin antibodies and uses thereof
GB201714734D0 (en) New compounds and uses
IL273157A (en) Axl-specific antibodies and uses thereof
IL271398A (en) Anti-l1-cam antibodies and uses thereof
IL269836B (en) Substituted n-arylethyl-2-aminoquinoline-4-carboxamides and use thereof
GB201712032D0 (en) Antibodies and uses thereof
GB201714736D0 (en) New compounds and uses
GB201709840D0 (en) Methods and medical uses
IL265531A (en) N 3 -cyclically substituted thienouraciles and use thereof
GB201712110D0 (en) New compounds and uses
IL274202A (en) Anti-glyco-muc1 antibodies and their uses
IL269843B (en) Substituted n-arylethyl-2-arylquinoline-4-carboxamides and use thereof
GB201715421D0 (en) Assays and medical uses
GB201720092D0 (en) New Compounds and uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)